Home Multidimensional protein identification technology for clinical proteomic analysis
Article
Licensed
Unlicensed Requires Authentication

Multidimensional protein identification technology for clinical proteomic analysis

  • Pierluigi Mauri and Michaela Scigelova
Published/Copyright: June 1, 2009

Abstract

Proteomics technologies demonstrate enormous data-gathering capabilities to discover disease-specific biomarkers in serum, plasma, urine, tissue and other biological samples. The traditional way to achieve this consists of protein separation performed using two-dimensional polyacrylamide gel electrophoresis (2DE). However, the 2DE approach has its drawbacks with respect to automation, sensitivity, and throughput. Considerable efforts have been devoted to the development of non-gel-based proteome separation technologies able to resolve complex protein and peptide mixtures prior to mass spectrometric (MS) analysis. This review discusses some of the most recent advances in multidimensional peptide separation techniques compatible with MS analysis, including gel electrophoresis, isoelectric focusing, capillary electrophoresis and liquid chromatography techniques. Based on future perspectives and our experiences, special attention is given to the application of two-dimensional chromatographic separation coupled to MS, the so-called multidimensional protein identification technology approach.

Clin Chem Lab Med 2009;47:636–46.


Corresponding author: Pierluigi Mauri, Institute for Biomedical Technologies, Via Fratelli Cervi 93, 20090 Segrate (Milan), Italy Phone: +39 0226422728, Fax: +39 0262422770,

Received: 2009-3-7
Accepted: 2009-4-20
Published Online: 2009-06-01
Published in Print: 2009-06-01

©2009 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. A focus on recent advances in proteomics – one step closer to entrance into the clinical arena
  3. Reviews
  4. Proteomics in protein misfolding diseases
  5. Multidimensional protein identification technology for clinical proteomic analysis
  6. Technical advances in proteomics mass spectrometry: identification of post-translational modifications
  7. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective
  8. Research Papers
  9. Thrombin induces broad spectrum proteolysis in human serum samples
  10. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS)
  11. Proteomics of exhaled breath: methodological nuances and pitfalls
  12. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry
  13. Approaching clinical proteomics: current state and future fields of application in fluid proteomics
  14. Genetics and Molecular Diagnostics
  15. Detection of Hpdel in healthy individuals and cancer patients in Taiwan
  16. Increased CA 19-9 level in patients without malignant disease
  17. General Clinical Chemistry and Laboratory Medicine
  18. Quantitation of cerebrospinal fluid lactic acid in infectious and non-infectious neurological diseases
  19. Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study
  20. Reference Values and Biological Variations
  21. Influence of tourniquet application on venous blood sampling for serum chemistry, hematological parameters, leukocyte activation and erythrocyte mechanical properties
  22. Systemic cytokine response following exercise-induced muscle damage in humans
  23. Letters to the Editor
  24. CACNA1A gene non-synonymous single nucleotide polymorphisms and common migraine in Italy: a case-control association study with a micro-array technology
  25. Proficiency test of plasma free and total metanephrines: report from a study group
Downloaded on 22.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.165/html
Scroll to top button